FDA approves 'ketamine' nasal spray for depression — here's everything you need to know
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant Depression
People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
What to Know About the New Nasal Spray for Tough Depression
CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more medication.
Ketamine-derived nasal spray treating Phoenix patients with severe depression
A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment isn’t working, but it’s not without risk.
J&J's ketamine-derived nasal spray approved by FDA to treat depression
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.
Can a Nasal Spray Really Help Treat Depression? Here's What to Know About Spravato
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earnings
Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral antidepressants.
Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
FDA-approved nasal spray for severe depression can lead to remission
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least two oral antidepressants.
Research indicates recreational ketamine use is on the rise
Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...
Low-dose oral ketamine shows promise in treating PTSD symptoms
A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...
Colorado clinic explores different ways to address mental health with ketamine-assisted therapy
A clinic in Arapahoe County is exploring new ways to help patients by offering ketamine-assisted psychotherapy.
Daily Camera2d
Boulder Community Health now offering ketamine therapy, other therapies for treatment-resistant conditions
Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...
unilad12h
Doctor explains terrifying impacts of taking 6g of ketamine a day as Emily Willis is left 'permanently disabled'
A doctor has explained what taking six grams of ketamine every day can do to the body after former adult film star Emily ...
KADN15h
Covering Your Health: New depression drug offers hope
For those with major depression, there is a new treatment option - one that offers hope when patients are not responding to ...
Ketamine warning after potentially deadly drug leaves youngsters with irreversible bladder issues and 'wearing nappies' for rest of their lives
Young ketamine users face irreversible bladder issues and risk 'wearing nappies' for all of their lives, a judge has warned. ...
Man hospitalized after being stabbed in Phoenix
People in Phoenix suffering from severe depression now have a Ketamine-derived nasal spray available for treatment. The feds ...